|
1
|
Singh P, Mittal R, Chandak S, Bhondey A,
Rathi A and Chandwani M: Prevalence of oral submucous fibrosis in
children of rural areas of Nagpur, Maharashtra, India. Int J Prev
Clinic Dent Res. 3:243–245. 2016.
|
|
2
|
Venkatesh R, Shah PH, More CB and Patil
DJ: Insight into history of Areca nut and oral submucous fibrosis:
A narrative review. Indian J Hist. Sci. 57:87–90. 2022.
|
|
3
|
Hande AH, Chaudhary MS, Gawande MN,
Gadbail AR, Zade PR, Bajaj S, Patil SK and Tekade S: Oral submucous
fibrosis: An enigmatic morpho-insight. J Cancer Res Ther.
15:463–469. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shah PH, Venkatesh R, More CB and
Vassandacoumara V: Comparison of therapeutic efficacy of placental
extract with dexamethasone and hyaluronic acid with dexamethasone
for oral submucous fibrosis-A retrospective analysis. J Clin Diagn
Res. 10:ZC63–ZC66. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
James L, Shetty A, Rishi D and Abraham M:
Management of oral submucous fibrosis with injection of
hyaluronidase and dexamethasone in grade III oral submucous
fibrosis: A retrospective study. J Int Oral Health. 7:82–85.
2015.PubMed/NCBI
|
|
6
|
Reddy CN, Belaldavar BP and Havaldar RR:
study of efficacy of intraoral submucosal injections of
corticosteroids and placentrex in the management of oral submucous
fibrosis. Indian J Otolaryngol Head Neck Surg. 74 (Suppl
2):S1996–S2001. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kisave P, Shekhar V, Babu PS, Hussaini
SWU, Bhanot R, Kumar A and Tiwari RVC: The study of placentrex and
hydrocortisone as an adjunct treatment in oral submucous fibrosis.
J Family Med Prim Care. 9:2469–2474. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Naik SM, Appaji MK, Ravishankara S,
Goutham MK, Devi NP, Mushannavar AS and Naik SS: Comparative study
of intralesional triamcinolone acetonide and hyaluronidasevs
placental extract in 60 Cases of oral submucous fibrosis. Int J
Head Neck Surg. 3:59–65. 2012.
|
|
9
|
Hariton E and Locascio JJ: Randomised
controlled trials- the gold standard for effectiveness research:
Study design: Randomised controlled trials. BJOG.
125(1716)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Passi D, Bhanot P, Kacker D, Chahal D,
Atri M and Panwar Y: Oral submucous fibrosis: Newer proposed
classification with critical updates in pathogenesis and management
strategies. Natl J Maxillofac Surg. 8:89–94. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rai A, Shrivastava PK, Kumar A, Kumar A,
Prasad K, Shakeel S and Ul Haque Z: Comparative effectiveness of
medicinal interventions for oral submucous fibrosis: A network
meta-analysis. J Stomatol Oral Maxillofac Surg.
124(101423)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sharma SR, Chavan S, Karjodkar FR, Sansare
K, Bharathi S and Singh S: Correlation of Clinical features in oral
submucous fibrosis: A 9-year retrospective study. Ethiop J Health
Sci. 32:137–44. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zuali L, Mohiyuddin SMA, A S, Mohammadi K
and Paul I: Comparison between clinical outcome of intralesional
human placental extract alone and topical application of placental
extract gel after fibrotomy in oral submucous fibrosis. Cureus.
15(e40105)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gupta S, Sharma M, Banerjee S, Holikatti
K, Kamble P and Goyal JV: The immunolocalization of mast cells in
the pathology of oral submucous fibrosis. Cureus.
15(e40069)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shao Z, Xu J, Xu X, Wang X, Zhou Y, Li Y
and Li K: Exosomes derived from human adipose mesenchymal stem
cells inhibits fibrosis and treats oral submucous fibrosis via the
miR-181a-5p/Smad2 Axis. Tissue Eng Regen Med. 21:123–135.
2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Abidullah M, Gaddikeri K, Anjum B,
Vairagare S, Tarani K and Seethamsetty S: Evaluation of
hematological profile in oral submucous fibrosis. Cureus.
14(e21926)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bhattacharya PT, Khaitan T, Sarkar SB and
Sinha R: Oral submucous fibrosis secondary to iron deficiency
anemia: A case report, etiopathogenesis and management. J Nutr
Health Aging. 20:205–208. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu H, Lyu FY, Song JY, Xu YM, Jiang EH,
Shang ZJ, Chen LL and Xu Z: Research achievements of oral submucous
fibrosis: Progress and prospect. Biomed Res Int.
2021(6631856)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Singh DT, Padshetty S, Shreen S, Begum N,
Vishwakarma SK and Khan AA: Injection placental in the management
of oral submucous fibrosis. Int J Mod Sci Eng Technol. 2:23–30.
2015.
|
|
20
|
Tilakaratne WM, Ekanayaka RP, Herath M,
Jayasinghe RD, Sitheeque M and Amarasinghe H: Intralesional
corticosteroids as a treatment for restricted mouth opening in oral
submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol.
122:224–231. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shrinivas , Shushma G and Kantly R:
Management of oral submucous fibrosis by combined oral medication
and intralesional injection: A treatment strategy. MedPulse-Int J
Dent. 7:1–5. 2018.
|
|
22
|
Borle RM and Borle SR: Management of oral
submucous fibrosis: A conservative approach. J Oral Maxillofac
Surg. 49:788–791. 1991.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shen YW, Shih YH, Fuh LJ and Shieh TM:
Oral submucous fibrosis: A review on biomarkers, pathogenic
mechanisms, and treatments. Int J Mol Sci. 21(7231)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gondivkar SM, Gadbail AR, Sarode SC,
Gondivkar RS, Patil S, Gaikwad RN and Yuwanati M: Clinical efficacy
of mouth exercising devices in oral submucous fibrosis: A
systematic review. J Oral Biol Craniofac Res. 10:315–320.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
More CB, Jatti Patil D and Rao NR:
Medicinal management of oral submucous fibrosis in the past
decade-A systematic review. J Oral Biol Craniofac Res. 10:552–568.
2020.PubMed/NCBI View Article : Google Scholar
|
